Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Medical Antifungal Agent Market Growth 2022-2028

  • LP 4965331
  • 119 Pages
  • June 2022
  • Healthcare
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Medical Antifungal Agent will have significant change from previous year. According to our (LP Information) latest study, the global Medical Antifungal Agent market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Medical Antifungal Agent market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Medical Antifungal Agent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Medical Antifungal Agent market, reaching US$ million by the year 2028. As for the Europe Medical Antifungal Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Medical Antifungal Agent players cover Novartis, Pfizer, Bayer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Antifungal Agent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Azoles

Echinocandins

Polyenes

Allylamines

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Dermatophytosis

Aspergillosis

Candidiasis

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

Pfizer

Bayer

Sanofi

Merck & Co

GlaxoSmithKline

MSD Manuals

Abbott

Glenmark

Enzon Pharmaceuticals

Astellas Pharma

Scynexis

Cidara Therapeutics

Lucigen Corporation

Biosergen

F2G

Sichuan Meidakang Pharmaceutical

Chengdu Taihe Health Technology

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Medical Antifungal Agent Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Medical Antifungal Agent by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Medical Antifungal Agent by Country/Region, 2017, 2022 & 2028

2.2 Medical Antifungal Agent Segment by Type

2.2.1 Azoles

2.2.2 Echinocandins

2.2.3 Polyenes

2.2.4 Allylamines

2.2.5 Others

2.3 Medical Antifungal Agent Sales by Type

2.3.1 Global Medical Antifungal Agent Sales Market Share by Type (2017-2022)

2.3.2 Global Medical Antifungal Agent Revenue and Market Share by Type (2017-2022)

2.3.3 Global Medical Antifungal Agent Sale Price by Type (2017-2022)

2.4 Medical Antifungal Agent Segment by Application

2.4.1 Dermatophytosis

2.4.2 Aspergillosis

2.4.3 Candidiasis

2.4.4 Others

2.5 Medical Antifungal Agent Sales by Application

2.5.1 Global Medical Antifungal Agent Sale Market Share by Application (2017-2022)

2.5.2 Global Medical Antifungal Agent Revenue and Market Share by Application (2017-2022)

2.5.3 Global Medical Antifungal Agent Sale Price by Application (2017-2022)

3 Global Medical Antifungal Agent by Company

3.1 Global Medical Antifungal Agent Breakdown Data by Company

3.1.1 Global Medical Antifungal Agent Annual Sales by Company (2020-2022)

3.1.2 Global Medical Antifungal Agent Sales Market Share by Company (2020-2022)

3.2 Global Medical Antifungal Agent Annual Revenue by Company (2020-2022)

3.2.1 Global Medical Antifungal Agent Revenue by Company (2020-2022)

3.2.2 Global Medical Antifungal Agent Revenue Market Share by Company (2020-2022)

3.3 Global Medical Antifungal Agent Sale Price by Company

3.4 Key Manufacturers Medical Antifungal Agent Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Medical Antifungal Agent Product Location Distribution

3.4.2 Players Medical Antifungal Agent Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Medical Antifungal Agent by Geographic Region

4.1 World Historic Medical Antifungal Agent Market Size by Geographic Region (2017-2022)

4.1.1 Global Medical Antifungal Agent Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Medical Antifungal Agent Annual Revenue by Geographic Region

4.2 World Historic Medical Antifungal Agent Market Size by Country/Region (2017-2022)

4.2.1 Global Medical Antifungal Agent Annual Sales by Country/Region (2017-2022)

4.2.2 Global Medical Antifungal Agent Annual Revenue by Country/Region

4.3 Americas Medical Antifungal Agent Sales Growth

4.4 APAC Medical Antifungal Agent Sales Growth

4.5 Europe Medical Antifungal Agent Sales Growth

4.6 Middle East & Africa Medical Antifungal Agent Sales Growth

5 Americas

5.1 Americas Medical Antifungal Agent Sales by Country

5.1.1 Americas Medical Antifungal Agent Sales by Country (2017-2022)

5.1.2 Americas Medical Antifungal Agent Revenue by Country (2017-2022)

5.2 Americas Medical Antifungal Agent Sales by Type

5.3 Americas Medical Antifungal Agent Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Medical Antifungal Agent Sales by Region

6.1.1 APAC Medical Antifungal Agent Sales by Region (2017-2022)

6.1.2 APAC Medical Antifungal Agent Revenue by Region (2017-2022)

6.2 APAC Medical Antifungal Agent Sales by Type

6.3 APAC Medical Antifungal Agent Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Medical Antifungal Agent by Country

7.1.1 Europe Medical Antifungal Agent Sales by Country (2017-2022)

7.1.2 Europe Medical Antifungal Agent Revenue by Country (2017-2022)

7.2 Europe Medical Antifungal Agent Sales by Type

7.3 Europe Medical Antifungal Agent Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Medical Antifungal Agent by Country

8.1.1 Middle East & Africa Medical Antifungal Agent Sales by Country (2017-2022)

8.1.2 Middle East & Africa Medical Antifungal Agent Revenue by Country (2017-2022)

8.2 Middle East & Africa Medical Antifungal Agent Sales by Type

8.3 Middle East & Africa Medical Antifungal Agent Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Medical Antifungal Agent

10.3 Manufacturing Process Analysis of Medical Antifungal Agent

10.4 Industry Chain Structure of Medical Antifungal Agent

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Medical Antifungal Agent Distributors

11.3 Medical Antifungal Agent Customer

12 World Forecast Review for Medical Antifungal Agent by Geographic Region

12.1 Global Medical Antifungal Agent Market Size Forecast by Region

12.1.1 Global Medical Antifungal Agent Forecast by Region (2023-2028)

12.1.2 Global Medical Antifungal Agent Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Medical Antifungal Agent Forecast by Type

12.7 Global Medical Antifungal Agent Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Medical Antifungal Agent Product Offered

13.1.3 Novartis Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Medical Antifungal Agent Product Offered

13.2.3 Pfizer Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Bayer

13.3.1 Bayer Company Information

13.3.2 Bayer Medical Antifungal Agent Product Offered

13.3.3 Bayer Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer Main Business Overview

13.3.5 Bayer Latest Developments

13.4 Sanofi

13.4.1 Sanofi Company Information

13.4.2 Sanofi Medical Antifungal Agent Product Offered

13.4.3 Sanofi Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Main Business Overview

13.4.5 Sanofi Latest Developments

13.5 Merck & Co

13.5.1 Merck & Co Company Information

13.5.2 Merck & Co Medical Antifungal Agent Product Offered

13.5.3 Merck & Co Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck & Co Main Business Overview

13.5.5 Merck & Co Latest Developments

13.6 GlaxoSmithKline

13.6.1 GlaxoSmithKline Company Information

13.6.2 GlaxoSmithKline Medical Antifungal Agent Product Offered

13.6.3 GlaxoSmithKline Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GlaxoSmithKline Main Business Overview

13.6.5 GlaxoSmithKline Latest Developments

13.7 MSD Manuals

13.7.1 MSD Manuals Company Information

13.7.2 MSD Manuals Medical Antifungal Agent Product Offered

13.7.3 MSD Manuals Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 MSD Manuals Main Business Overview

13.7.5 MSD Manuals Latest Developments

13.8 Abbott

13.8.1 Abbott Company Information

13.8.2 Abbott Medical Antifungal Agent Product Offered

13.8.3 Abbott Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Abbott Main Business Overview

13.8.5 Abbott Latest Developments

13.9 Glenmark

13.9.1 Glenmark Company Information

13.9.2 Glenmark Medical Antifungal Agent Product Offered

13.9.3 Glenmark Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Glenmark Main Business Overview

13.9.5 Glenmark Latest Developments

13.10 Enzon Pharmaceuticals

13.10.1 Enzon Pharmaceuticals Company Information

13.10.2 Enzon Pharmaceuticals Medical Antifungal Agent Product Offered

13.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Enzon Pharmaceuticals Main Business Overview

13.10.5 Enzon Pharmaceuticals Latest Developments

13.11 Astellas Pharma

13.11.1 Astellas Pharma Company Information

13.11.2 Astellas Pharma Medical Antifungal Agent Product Offered

13.11.3 Astellas Pharma Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Astellas Pharma Main Business Overview

13.11.5 Astellas Pharma Latest Developments

13.12 Scynexis

13.12.1 Scynexis Company Information

13.12.2 Scynexis Medical Antifungal Agent Product Offered

13.12.3 Scynexis Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Scynexis Main Business Overview

13.12.5 Scynexis Latest Developments

13.13 Cidara Therapeutics

13.13.1 Cidara Therapeutics Company Information

13.13.2 Cidara Therapeutics Medical Antifungal Agent Product Offered

13.13.3 Cidara Therapeutics Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Cidara Therapeutics Main Business Overview

13.13.5 Cidara Therapeutics Latest Developments

13.14 Lucigen Corporation

13.14.1 Lucigen Corporation Company Information

13.14.2 Lucigen Corporation Medical Antifungal Agent Product Offered

13.14.3 Lucigen Corporation Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Lucigen Corporation Main Business Overview

13.14.5 Lucigen Corporation Latest Developments

13.15 Biosergen

13.15.1 Biosergen Company Information

13.15.2 Biosergen Medical Antifungal Agent Product Offered

13.15.3 Biosergen Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Biosergen Main Business Overview

13.15.5 Biosergen Latest Developments

13.16 F2G

13.16.1 F2G Company Information

13.16.2 F2G Medical Antifungal Agent Product Offered

13.16.3 F2G Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 F2G Main Business Overview

13.16.5 F2G Latest Developments

13.17 Sichuan Meidakang Pharmaceutical

13.17.1 Sichuan Meidakang Pharmaceutical Company Information

13.17.2 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Offered

13.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Sichuan Meidakang Pharmaceutical Main Business Overview

13.17.5 Sichuan Meidakang Pharmaceutical Latest Developments

13.18 Chengdu Taihe Health Technology

13.18.1 Chengdu Taihe Health Technology Company Information

13.18.2 Chengdu Taihe Health Technology Medical Antifungal Agent Product Offered

13.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Chengdu Taihe Health Technology Main Business Overview

13.18.5 Chengdu Taihe Health Technology Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Medical Antifungal Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Medical Antifungal Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Azoles

Table 4. Major Players of Echinocandins

Table 5. Major Players of Polyenes

Table 6. Major Players of Allylamines

Table 7. Major Players of Others

Table 8. Global Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)

Table 9. Global Medical Antifungal Agent Sales Market Share by Type (2017-2022)

Table 10. Global Medical Antifungal Agent Revenue by Type (2017-2022) & ($ million)

Table 11. Global Medical Antifungal Agent Revenue Market Share by Type (2017-2022)

Table 12. Global Medical Antifungal Agent Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)

Table 14. Global Medical Antifungal Agent Sales Market Share by Application (2017-2022)

Table 15. Global Medical Antifungal Agent Revenue by Application (2017-2022)

Table 16. Global Medical Antifungal Agent Revenue Market Share by Application (2017-2022)

Table 17. Global Medical Antifungal Agent Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Medical Antifungal Agent Sales by Company (2020-2022) & (K Units)

Table 19. Global Medical Antifungal Agent Sales Market Share by Company (2020-2022)

Table 20. Global Medical Antifungal Agent Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Medical Antifungal Agent Revenue Market Share by Company (2020-2022)

Table 22. Global Medical Antifungal Agent Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Medical Antifungal Agent Producing Area Distribution and Sales Area

Table 24. Players Medical Antifungal Agent Products Offered

Table 25. Medical Antifungal Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Medical Antifungal Agent Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Medical Antifungal Agent Sales Market Share Geographic Region (2017-2022)

Table 30. Global Medical Antifungal Agent Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Medical Antifungal Agent Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Medical Antifungal Agent Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Medical Antifungal Agent Sales Market Share by Country/Region (2017-2022)

Table 34. Global Medical Antifungal Agent Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Medical Antifungal Agent Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)

Table 37. Americas Medical Antifungal Agent Sales Market Share by Country (2017-2022)

Table 38. Americas Medical Antifungal Agent Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Medical Antifungal Agent Revenue Market Share by Country (2017-2022)

Table 40. Americas Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)

Table 41. Americas Medical Antifungal Agent Sales Market Share by Type (2017-2022)

Table 42. Americas Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)

Table 43. Americas Medical Antifungal Agent Sales Market Share by Application (2017-2022)

Table 44. APAC Medical Antifungal Agent Sales by Region (2017-2022) & (K Units)

Table 45. APAC Medical Antifungal Agent Sales Market Share by Region (2017-2022)

Table 46. APAC Medical Antifungal Agent Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Medical Antifungal Agent Revenue Market Share by Region (2017-2022)

Table 48. APAC Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)

Table 49. APAC Medical Antifungal Agent Sales Market Share by Type (2017-2022)

Table 50. APAC Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)

Table 51. APAC Medical Antifungal Agent Sales Market Share by Application (2017-2022)

Table 52. Europe Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)

Table 53. Europe Medical Antifungal Agent Sales Market Share by Country (2017-2022)

Table 54. Europe Medical Antifungal Agent Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Medical Antifungal Agent Revenue Market Share by Country (2017-2022)

Table 56. Europe Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)

Table 57. Europe Medical Antifungal Agent Sales Market Share by Type (2017-2022)

Table 58. Europe Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)

Table 59. Europe Medical Antifungal Agent Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Medical Antifungal Agent Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Medical Antifungal Agent Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Medical Antifungal Agent Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Medical Antifungal Agent Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Medical Antifungal Agent Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Medical Antifungal Agent

Table 69. Key Market Challenges & Risks of Medical Antifungal Agent

Table 70. Key Industry Trends of Medical Antifungal Agent

Table 71. Medical Antifungal Agent Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Medical Antifungal Agent Distributors List

Table 74. Medical Antifungal Agent Customer List

Table 75. Global Medical Antifungal Agent Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Medical Antifungal Agent Sales Market Forecast by Region

Table 77. Global Medical Antifungal Agent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Medical Antifungal Agent Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Medical Antifungal Agent Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Medical Antifungal Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Medical Antifungal Agent Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Medical Antifungal Agent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Medical Antifungal Agent Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Medical Antifungal Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Medical Antifungal Agent Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Medical Antifungal Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Medical Antifungal Agent Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Medical Antifungal Agent Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Medical Antifungal Agent Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Medical Antifungal Agent Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Medical Antifungal Agent Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Medical Antifungal Agent Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Medical Antifungal Agent Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Medical Antifungal Agent Revenue Market Share Forecast by Application (2023-2028)

Table 95. Novartis Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 96. Novartis Medical Antifungal Agent Product Offered

Table 97. Novartis Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Novartis Main Business

Table 99. Novartis Latest Developments

Table 100. Pfizer Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 101. Pfizer Medical Antifungal Agent Product Offered

Table 102. Pfizer Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Pfizer Main Business

Table 104. Pfizer Latest Developments

Table 105. Bayer Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 106. Bayer Medical Antifungal Agent Product Offered

Table 107. Bayer Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Bayer Main Business

Table 109. Bayer Latest Developments

Table 110. Sanofi Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 111. Sanofi Medical Antifungal Agent Product Offered

Table 112. Sanofi Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Sanofi Main Business

Table 114. Sanofi Latest Developments

Table 115. Merck & Co Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 116. Merck & Co Medical Antifungal Agent Product Offered

Table 117. Merck & Co Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Merck & Co Main Business

Table 119. Merck & Co Latest Developments

Table 120. GlaxoSmithKline Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 121. GlaxoSmithKline Medical Antifungal Agent Product Offered

Table 122. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. GlaxoSmithKline Main Business

Table 124. GlaxoSmithKline Latest Developments

Table 125. MSD Manuals Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 126. MSD Manuals Medical Antifungal Agent Product Offered

Table 127. MSD Manuals Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. MSD Manuals Main Business

Table 129. MSD Manuals Latest Developments

Table 130. Abbott Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 131. Abbott Medical Antifungal Agent Product Offered

Table 132. Abbott Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Abbott Main Business

Table 134. Abbott Latest Developments

Table 135. Glenmark Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 136. Glenmark Medical Antifungal Agent Product Offered

Table 137. Glenmark Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Glenmark Main Business

Table 139. Glenmark Latest Developments

Table 140. Enzon Pharmaceuticals Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 141. Enzon Pharmaceuticals Medical Antifungal Agent Product Offered

Table 142. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Enzon Pharmaceuticals Main Business

Table 144. Enzon Pharmaceuticals Latest Developments

Table 145. Astellas Pharma Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 146. Astellas Pharma Medical Antifungal Agent Product Offered

Table 147. Astellas Pharma Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Astellas Pharma Main Business

Table 149. Astellas Pharma Latest Developments

Table 150. Scynexis Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 151. Scynexis Medical Antifungal Agent Product Offered

Table 152. Scynexis Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Scynexis Main Business

Table 154. Scynexis Latest Developments

Table 155. Cidara Therapeutics Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 156. Cidara Therapeutics Medical Antifungal Agent Product Offered

Table 157. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Cidara Therapeutics Main Business

Table 159. Cidara Therapeutics Latest Developments

Table 160. Lucigen Corporation Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 161. Lucigen Corporation Medical Antifungal Agent Product Offered

Table 162. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Lucigen Corporation Main Business

Table 164. Lucigen Corporation Latest Developments

Table 165. Biosergen Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 166. Biosergen Medical Antifungal Agent Product Offered

Table 167. Biosergen Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 168. Biosergen Main Business

Table 169. Biosergen Latest Developments

Table 170. F2G Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 171. F2G Medical Antifungal Agent Product Offered

Table 172. F2G Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 173. F2G Main Business

Table 174. F2G Latest Developments

Table 175. Sichuan Meidakang Pharmaceutical Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 176. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Offered

Table 177. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 178. Sichuan Meidakang Pharmaceutical Main Business

Table 179. Sichuan Meidakang Pharmaceutical Latest Developments

Table 180. Chengdu Taihe Health Technology Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors

Table 181. Chengdu Taihe Health Technology Medical Antifungal Agent Product Offered

Table 182. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 183. Chengdu Taihe Health Technology Main Business

Table 184. Chengdu Taihe Health Technology Latest Developments

List of Figures

Figure 1. Picture of Medical Antifungal Agent

Figure 2. Medical Antifungal Agent Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Medical Antifungal Agent Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Medical Antifungal Agent Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Medical Antifungal Agent Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Azoles

Figure 10. Product Picture of Echinocandins

Figure 11. Product Picture of Polyenes

Figure 12. Product Picture of Allylamines

Figure 13. Product Picture of Others

Figure 14. Global Medical Antifungal Agent Sales Market Share by Type in 2021

Figure 15. Global Medical Antifungal Agent Revenue Market Share by Type (2017-2022)

Figure 16. Medical Antifungal Agent Consumed in Dermatophytosis

Figure 17. Global Medical Antifungal Agent Market: Dermatophytosis (2017-2022) & (K Units)

Figure 18. Medical Antifungal Agent Consumed in Aspergillosis

Figure 19. Global Medical Antifungal Agent Market: Aspergillosis (2017-2022) & (K Units)

Figure 20. Medical Antifungal Agent Consumed in Candidiasis

Figure 21. Global Medical Antifungal Agent Market: Candidiasis (2017-2022) & (K Units)

Figure 22. Medical Antifungal Agent Consumed in Others

Figure 23. Global Medical Antifungal Agent Market: Others (2017-2022) & (K Units)

Figure 24. Global Medical Antifungal Agent Sales Market Share by Application (2017-2022)

Figure 25. Global Medical Antifungal Agent Revenue Market Share by Application in 2021

Figure 26. Medical Antifungal Agent Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Medical Antifungal Agent Revenue Market Share by Company in 2021

Figure 28. Global Medical Antifungal Agent Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Medical Antifungal Agent Revenue Market Share by Geographic Region in 2021

Figure 30. Global Medical Antifungal Agent Sales Market Share by Region (2017-2022)

Figure 31. Global Medical Antifungal Agent Revenue Market Share by Country/Region in 2021

Figure 32. Americas Medical Antifungal Agent Sales 2017-2022 (K Units)

Figure 33. Americas Medical Antifungal Agent Revenue 2017-2022 ($ Millions)

Figure 34. APAC Medical Antifungal Agent Sales 2017-2022 (K Units)

Figure 35. APAC Medical Antifungal Agent Revenue 2017-2022 ($ Millions)

Figure 36. Europe Medical Antifungal Agent Sales 2017-2022 (K Units)

Figure 37. Europe Medical Antifungal Agent Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Medical Antifungal Agent Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Medical Antifungal Agent Revenue 2017-2022 ($ Millions)

Figure 40. Americas Medical Antifungal Agent Sales Market Share by Country in 2021

Figure 41. Americas Medical Antifungal Agent Revenue Market Share by Country in 2021

Figure 42. United States Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Medical Antifungal Agent Sales Market Share by Region in 2021

Figure 47. APAC Medical Antifungal Agent Revenue Market Share by Regions in 2021

Figure 48. China Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Medical Antifungal Agent Sales Market Share by Country in 2021

Figure 55. Europe Medical Antifungal Agent Revenue Market Share by Country in 2021

Figure 56. Germany Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Medical Antifungal Agent Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Medical Antifungal Agent Revenue Market Share by Country in 2021

Figure 63. Egypt Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Medical Antifungal Agent in 2021

Figure 69. Manufacturing Process Analysis of Medical Antifungal Agent

Figure 70. Industry Chain Structure of Medical Antifungal Agent

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370